Table 5:
Subgroup Analyses of Behaviour, Fear of Hypoglycemia, and Quality of Life for People With Type 1 Diabetes Treated With Multiple Daily Injections and Insulin Pump Therapy
| Variable | Type 1 Diabetes Treated With MD | Type 1 Diabetes Treated With Insulin Pump | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline Using SMBG | 3 Mo After Using Flash | Difference (95% CI)a | P Valuea | Baseline Using SMBG | 3 Mo After Using Flash | Difference (95% CI)a | P Valuea | |
| Behaviour | 1.97 | 2.1 | 0.13 (0.07 to 0.19) |
.0001 | 1.8 | 2.09 | 0.29 (0.16 to 0.42) |
.0001 |
| Worry (fear of hypoglycemia) | 2.02 | 1.8 | −0.22 (−0.32 to −0.12) |
.0001 | 1.88 | 1.75 | −0.13 (−0.19 to −0.07) |
.0001 |
| Quality of life | 44.7 | 50.6 | 5.9 (2.20 to 9.60) |
.0030 | 46.8 | 48.2 | 1.4 (−1.44 to 4.25) |
.3342 |
Abbreviations: CI, confidence intervals; MDI, multiple daily injections of insulin; SMBG, self-monitoring of blood glucose.
a
Confidence intervals and P values were computed by the authors of this health technology assessment using information reported in the primary studies.
Source: Al Hayek et al.47